Health & Pharmaceutical Landscape of New Zealand | March 2022

Page 25

The four Factors for Consideration are: 1. 2. 3. 4.

Need Health Benefits Costs and Savings Suitability

Each factor has 3 different aspects: • • •

the individual the family, [whanau] and society the health system.

Putting the Factors to work The factors help PHARMAC assess each funding application against its statutory objective. They help answer the question: Does the proposal or decision help PHARMAC to secure for eligible people in need of pharmaceuticals the best health outcomes that are reasonably achievable from pharmaceuticals treatment and from within the amount of funding provided? PHARMAC will mainly use the Factors for Consideration when making funding decisions, both decisions relating to treatments being listed on the Pharmaceutical Schedule, and also for decisions for individual patients through PHARMAC’S Named Patient Pharmaceutical Assessment Policy. When relevant, they also endeavour to use these Factors when making other decisions that relate to their statutory functions set out in the New Zealand Public Health and Disability Act 2000. This could include making decisions to support the responsible use of medicines. Not every factor may be relevant to every funding decision PHARMAC makes Some factors may be more or less relevant (or may not be relevant at all) depending on the type and nature of the decision being made and, therefore, judgement is always required. Having the ability to exercise this judgement is critical to PHARMAC’S role as it enables them to respond appropriately to a broad range of situations. Every funding decision must be considered in relation to the amount of funding available PHARMAC considers every funding decision in relation to how funding the given treatment may impact on the Combined Pharmaceutical Budget, District Health Board (DHB) hospital budgets and the overall Vote Health budget as applicable, for both the current financial year and over future years. Source: [3] PHARMAC

Healthcare & Pharmaceutical Landscape of NZ

25


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Support provided by Make in India / Invest India team

1min
page 91

Are there any incentives?

1min
page 90

What is the policy framework for foreign pharma companies to manufacture / collaborate with Indian companies?

0
page 89

List of important companies in New Zealand’s pharma sector

2min
pages 83-86

Media Extract: BURDEN OF PROOF IS ON MEDSAFE TO JUSTIFY ITS EXISTENCE

2min
pages 64-65

A Decade of Modern Medicines: An International Comparison 2011 – 2020

2min
page 56

Understanding the Supplemented Food Standards

0
page 60

Industry Perspective

2min
page 61

Other sources of information

0
page 62

Vaccines: PHARMAC’s role

2min
pages 53-54

Hospital Medical Devices

1min
page 52

Myths & FAQs on tendering process

0
page 51

How does the annual tender work?

3min
pages 48-50

From application to funded medicine: PHARMAC's process

2min
pages 45-46

Procurement & tendering process

1min
page 47

How PHARMAC gets clinical advice into their decision-making

1min
page 44

How new medicines get funded ?

3min
pages 40-41

How the health priorities affect PHARMAC's work

1min
page 42

Medical Devices

2min
pages 37-38

What do I need to do to sell my medicine in New Zealand?

2min
pages 35-36

How new medicines get funded by PHARMAC

0
page 24

Main agencies involved in managing the sector

4min
pages 9-11

Introductory Regulatory Guidance

3min
pages 33-34

Who is a Sponsor?

4min
pages 19-21

Putting the Factors to work

2min
pages 25-26

Foreword

1min
page 5

Medsafe's Evaluation and Approval Process

5min
pages 29-32

Foreword

2min
pages 6-7
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.